Enolase (EC 4.2.1.11) is the second to last step in glycolysis and the third step in gluconeogenesis, catalyzing the reversible conversation of 2-phosphoglycerate and phosphoenolpyruvate. Enolase is a key enzyme in energy metabolism and measuring its enzymatic activity is of interest to investigators in diverse fields, including those studying cancer cell metabolism. We describe a simple and rapid in vitro protocol to measure Enolase activity in native lysates from mammalian cells in culture.
Introduction
Enolase (EC 4.2.1.11) is the second to last step in glycolysis and the fourth step in gluconeogenesis, catalyzing the reversible conversation of 2-phosphoglycerate and phosphoenolpyruvate. Enolase is a key enzyme in energy metabolism and measuring its enzymatic activity in vitro is of interest to investigators in diverse fields, including those studying cancer cell metabolism. A variety of transition state analogues have been synthesized, some of which exhibit potent inhibitory activity, such as phosphonoacetohydroxamate 1, 2. The enzymatic assay described here diverges little from that used in biochemistry laboratories since the 1960's (1,2) and derives largely from the protocol found in the Sigma protocol archives http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/General_Information/... [1]). It has been used by our lab to measure Enolase activity in lysates from blood, mouse tissues and cells in culture. In principal, any lysis buffer that leaves Enolase proteins in their native state can be used, provided that fluoride is not present in excessive amounts in the final assay since the later ion can act as an Enolase-inhibitor (1).
The present Enolase assay measures NADH changes linked to Enolase by lactate dehydrogenase and pyruvate kinase. The general principle of the assay is as follows (illustrated below). Excess phosphoglycerate, pyruvate kinase, ADP and lactate dehydrogenase are provided in the assay, with the conversion of phosphoglycerate into phosphoenolpyruvate being rate limiting and performed by Enolase present in the biological samples to be assayed. Phosphoenolpyruvate is then converted to pyruvate by pyruvate kinase, and is used by lactate dehydrogenase to oxidize NADH. Changes in NADH are then followed either spectrophotometrically (when the absolute activity, in Units/mg protein is required) or more efficiently, fluorometrically (where knowledge of relative levels of Enolase activity is sufficient). The rate of NADH oxidation (decrease in absorbance at 340 nm or decrease in fluorescence excitation/emission 360/460 nm) is the actual read-out of the enolase activity assay. In fluorescent reading format, the assay is readily adaptable to 96-well format. Phosphonoacetohdroxamate is a highly potent inhibitor and can be used as a negative control (1). 
Instructions Preparation of biological test samples Sample preparation:
1. Grow mammalian cells under conventional conditions to around 90% confluence in 10-cm dishes. 2. Wash cells once with PBS and add 0.5mL of Lysis buffer (RIPA or NP-40 buffer may be used instead, but the specific Enolase activity is lower). 3. Scrape cells and place in 1.5mL Eppendorf tubes. 4. Break cells by sonification and then clear lysate by centrifugation at 20,000g for 30 minutes. 5. Determine protein concenration by spectrophotometrically using the Bradford method (Biorad #500-0006). 6. We routinely freeze samples at -80C until further analysis.
Assay procedure (fluorescent plate reader):
1. Prepare tow buffers, reaction buffer without 2PG (reaction buffer A) and reaction buffer with 2X (4.5 mM) 2PG (solution B). 2. Equalize the biological samples for protein concentration and pre-mix at dilutions from 1:500 to 1:10 with reaction buffer A (The enolase enzymatic reaction cannot start for lack of substrate, 2PG). 3. Prepare a second set of samples with the addition of 2µM PhAH as a negative control. 4. Mammalian blood (diluted 1:1 with lysis buffer, sonicated, and centrifuged at 20,000g) can be used as a positive control. These are aliquoted at 100uL in a 96 well plate (black walls, clear bottom) and a set of wells without added biological specimen (100uL buffer A alone) should be included as a negative control. 5. Start the reaction with the addition of 100uL of Buffer B (adding the enolase substrate, 2PG). This is best done using a multichannel pipet and start the fluorescence reading as quickly as possible. 6. Record fluorescence readings (NADH excitation 360nm, emission 460nm) every 30 seconds. 
